<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00861354</url>
  </required_header>
  <id_info>
    <org_study_id>tripps2</org_study_id>
    <nct_id>NCT00861354</nct_id>
  </id_info>
  <brief_title>Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor</brief_title>
  <acronym>TRIPPS</acronym>
  <official_title>Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor: Trial of Regular vs Irregualr Pulse for the Prevention of Stroke (TRIPPS 2.0)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Microlife</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Microlife</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study assess the accuracy of a blood pressure monitor designed to detect atrial
      fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and
      compare the readings to an ECG done at the same time.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of the blood pressure monitor used for detecting atrial fibrillation compared to the electrocardiogram.</measure>
    <time_frame>After final subject data is available.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess subjects understanding of the use of the device for atrial fibrillation.</measure>
    <time_frame>After final subject data is available.</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Microlife blood pressure monitor with AF detection (Microlife AFIB MLU3MQ1)</intervention_name>
    <description>Monitoring heart rhythm daily for 30 days using the blood pressure monitor and the ECG recorder.</description>
    <other_name>Microlife AFIB MLU3MQ1</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seen in a general medical practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: any of the following

          -  age 65 or older

          -  hypertension

          -  diabetes mellitus

          -  congestive heart failure

          -  previous stroke

        Exclusion Criteria:

          -  permanent pacemaker

          -  impalantable defibrillator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Wiesel, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Joseph Wiesel, MD medical office</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2009</study_first_submitted>
  <study_first_submitted_qc>March 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2009</study_first_posted>
  <last_update_submitted>January 6, 2010</last_update_submitted>
  <last_update_submitted_qc>January 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Joseph Wiesel, MD</name_title>
    <organization>Microlife</organization>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>home blood pressure monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

